Evidence map›Paper›PMID 40276511›Full record

ArticleFrontiers in immunology2025

HnRNP L is essential for peripheral T cell proliferation and survival.

Tristan L A White, Devin J Henry, Sean D A Roberts, Ye Jin, Yi-Nan Gong, Penelope A Morel

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tristan L A WhiteDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Devin J HenryDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Sean D A RobertsDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Ye JinDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Yi-Nan GongDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Penelope A MorelDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: During T cell development, heterogeneous nuclear ribonucleoprotein (hnRNP) L is known to regulate CD4 T helper subset differentiation, the proliferation and migration of thymocytes, as loss of hnRNP L in early T cell development results in a failure of T cells to reach the periphery. Methods: To better understand the role of hnRNP L in modulating peripheral T cell trafficking and function, we analyzed T survival and activation in newly generated CD4Cre x hnRNP L Results: Our initial study of the steady state profile of the KO mice showed normal migration of T cells from the thymus, but peripheral T cell numbers were reduced. Analysis of TCR-mediated signaling pathways revealed normal early T cell activation. However, T cells lacking hnRNP L had marked defects in their ability to differentiate into T helper cell subsets due to reduced proliferation and increased death. In vivo, using immunization studies, KO CD4 T cells failed to fully differentiate into T follicular helper (Tfh) cells and were unable to support the formation of germinal center B cells. Death of activated hnRNP L KO cells could be reversed by treating the cells with zVAD, a pan-caspase inhibitor. In addition, hnRNP L KO cells failed to upregulate the anti-apoptotic protein Bcl-XL following activation. Discussion: These studies suggest that hnRNP L plays an important role in T cell activation and survival. Our studies suggest that hnRNP L plays a critical pro-survival role in activated T cells and that alternative splicing of factors that prevent apoptosis may be an important mechanism by which this is achieved.

Indexed as

CD4-Positive T-LymphocytesCell ProliferationHeterogeneous-Nuclear Ribonucleoprotein LLymphocyte ActivationAnimalsCell DifferentiationCell MovementCell SurvivalMiceMice, Inbred C57BLMice, KnockoutHeterogeneous-Nuclear Ribonucleoprotein LapoptosishnRNP LproliferationRNA binding proteinsT cell activationT helper cell subsets

Identifiers

PMID40276511
PMCPMC12018431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.